Class IIOngoingD-0370-2021
Drug recall · May 12, 2021
Burro en Primavera recall
Why: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Burro en Primavera, 2 capsules, UPC 638632431055
- Lots / codes
All
- Quantity
- 500 boxes
- Company
- QMart, Elmwood Park, NJ
- Distribution
- USA Nationwide
- Initiated
- March 31, 2021 · Voluntary: Firm initiated
- Classified
- May 6, 2021
- Reported
- May 12, 2021
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.